Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis
- 466 Downloads
In view of their age and vascular co-morbidities, people are often taking an antithrombotic drug when diagnosed with chronic subdural haematoma (CSDH). It is unclear whether antithrombotic use at CSDH diagnosis, or resumption afterwards, is associated with recurrent CSDH or vaso-occlusive events. We systematically reviewed the literature for studies reporting CSDH recurrence or vaso-occlusive events after drainage of CSDH associated with antithrombotic drug use. We searched Medline 1946–2016 and Embase 1974–2016 inclusive for cohort studies reporting the risk of CSDH recurrence or vaso-occlusive events after CSDH associated with antithrombotic (anticoagulant or antiplatelet) drug use. We meta-analysed outcome data using a random effect model and assessed inconsistency between studies using the I-squared (I 2) statistic. We found 20 studies reporting outcome after drainage of CSDH associated with antithrombotic drug use. Before CSDH drainage, 337 (11.5%) of 2941 patients in 12 studies used an anticoagulant drug and 600 (19%) of 3150 patients in 11 studies used an antiplatelet drug. The association between antithrombotic drug use and CSDH recurrence was significant for antiplatelet drug use (relative risk [RR] 1.36, 95% CI 1.05 to 1.75; I 2 = 36.3%), but marginally significant for anticoagulant drug use (RR 1.38 95% CI 1.00–1.91; I 2 = 37.5%). Two studies including 30 patients reported one vaso-occlusive outcome event after CSDH. Antithrombotic drug use at CSDH diagnosis may be associated with post-operative CSDH recurrence. It is unclear whether this is attributable to confounding factors, antithrombotic reversal strategies or antithrombotic drug resumption. Further observational studies and randomised controlled trials of antithrombotic drug resumption are needed.
KeywordsAnticoagulant Antiplatelet Chronic subdural haematoma Recurrence Systematic review
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval not applicable as this is a systematic review.
The nature of this article did not require informed consent.
- 21.Tugcu B, Tanriverdi O, Baydin S, Hergunsel B, Gunaldi O, Ofluoglu E, Alatas I, Demirgil B, Emel E (2014) Can recurrence of chronic subdural hematoma be predicted? A retrospective analysis of 292 cases. J Neurol Surg 75:37–41Google Scholar
- 23.Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S (2003) Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 98:1217–1221. doi: 10.3171/jns.2003.98.6.1217 CrossRefPubMedGoogle Scholar
- 27.Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272. doi: 10.1378/chest.09-1584 CrossRefPubMedGoogle Scholar
- 29.Chari A, Hocking K, Edlmann E, Turner C, Santarius T, Hutchinson PJ, Kolias AG (2015) Core outcomes and common data elements in chronic subdural Haematoma (CODE-CSDH): a systematic review of the literature focusing on baseline and peri-operative care data elements. J Neurotrauma. doi: 10.1089/neu.2015.4248